Johnson & Johnson: Heart Diseases trials

The registry lists 13 Heart Diseases studies with Johnson & Johnson as lead sponsor. 1 are open to participants now and 6 have results posted.

Phase 2 1Phase 3 6Phase 4 1No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac RecoveryRecruitingNCT06965504Not applicable
• An Upcoming Clinical Study to Measure the Safety and Impact of a Drug Called Macitentan in Teenage and Adult Fontan Patients.TerminatedNCT03775421Phase 3Results posted
• Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated SubjectsCompletedNCT03153137Phase 3Results posted
• THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial FibrillationCompletedNCT01385202Phase 3Results posted
• NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation- Treatment Use StudyTerminatedNCT00721149Phase 3Results posted
• Catheter Evaluation for Endocardial Ablation in Patients With Ventricular TachycardiaCompletedNCT00412607Phase 4Results posted
• NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial FibrillationCompletedNCT00116428Phase 3Results posted
• Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular FunctionActive, not recruitingNCT04763200Not applicable
• SVC Occlusion in Subjects With Acute Decompensated Heart FailureCompletedNCT03836079Not applicable
• Adult Congenital Heart Disease Registry (QuERI)CompletedNCT01659411
• CoStar Catheter System EvaluationTerminatedNCT00993785Phase 3
• AbioCor Implantable Replacement HeartNo longer availableNCT00669357
• Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPACompletedNCT00653042Phase 2